Staging laparoscopy for hilar cholangiocarcinoma in 100 patients.

PubWeight™: 0.94‹?› | Rank: Top 15%

🔗 View Article (PMID 23995711)

Published in Langenbecks Arch Surg on September 01, 2013

Authors

Adam D Barlow1, Guiseppe Garcea, David P Berry, Arumugam Rajesh, Roshni Patel, Matthew S Metcalfe, Ashley R Dennison

Author Affiliations

1: Departments of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK, adambarlow@doctors.net.uk.

Articles cited by this

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg (1998) 2.81

Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg (2002) 1.75

Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol (2008) 1.64

Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery (2007) 1.54

Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc (2006) 1.28

The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg (2005) 1.16

Staging laparoscopy for hilar cholangiocarcinoma: is it still worthwhile? Ann Surg Oncol (2011) 1.12

FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun (2001) 1.10

Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Br J Radiol (2012) 1.09

Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol (2008) 1.08

Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction. J Gastrointest Surg (2002) 1.03

FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma. HPB (Oxford) (2011) 0.89

Articles by these authors

Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011. MMWR Morb Mortal Wkly Rep (2014) 3.60

Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol (2012) 2.59

Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomarkers Prev (2011) 2.35

Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr (2012) 2.24

Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP (2008) 1.97

Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol (2005) 1.86

Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev (2005) 1.83

Single-incision laparoscopic cholecystectomy: a systematic review. Arch Surg (2012) 1.82

Total pancreatectomy with and without islet cell transplantation for chronic pancreatitis: a series of 85 consecutive patients. Pancreas (2009) 1.77

A clinically relevant approach to imaging prostate cancer: review. AJR Am J Roentgenol (2011) 1.71

Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer (2007) 1.65

Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases. Med Oncol (2015) 1.64

Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome). Blood (2012) 1.58

The incidence and success of treatment for severe chronic groin pain after open, transabdominal preperitoneal, and totally extraperitoneal hernia repair. World J Surg (2010) 1.55

Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer (2007) 1.55

Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs? Cancer Chemother Pharmacol (2009) 1.51

Pilot study of oral anthocyanins for colorectal cancer chemoprevention. Cancer Prev Res (Phila) (2009) 1.50

Is intraoperative confirmation of malignancy during pancreaticoduodenectomy mandatory? J Gastrointest Surg (2011) 1.50

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol (2007) 1.49

How much liver resection is too much? Am J Surg (2005) 1.40

Prevalence of smokefree home rules--United States, 1992-1993 and 2010-2011. MMWR Morb Mortal Wkly Rep (2014) 1.39

Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences. Clin Cancer Res (2006) 1.39

Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol (2011) 1.36

Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res (2009) 1.33

Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev (2008) 1.30

Liver metastases from colorectal cancer: radioembolization with systemic therapy. Nat Rev Clin Oncol (2009) 1.24

Islet auto transplantation following total pancreatectomy: a long-term assessment of graft function. Pancreas (2008) 1.24

Primary epiploic appendagitis: CT diagnosis. Emerg Radiol (2004) 1.22

Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review. Eur J Gastroenterol Hepatol (2009) 1.21

Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer (2008) 1.21

Systematic review of minimally invasive pancreatic resection. J Gastrointest Surg (2009) 1.21

Cohort study of operative delivery in the second stage of labour and standard of obstetric care. BJOG (2003) 1.14

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. Nature (2016) 1.13

Gastrointestinal stromal tumors: clinical, radiologic, and pathologic features. AJR Am J Roentgenol (2005) 1.13

Rectal cancer: incidence of pulmonary metastases on thoracic CT and correlation with T staging. J Comput Assist Tomogr (2007) 1.13

MR imaging of the small bowel: is MR enteroclysis the only valid first-line investigation? Radiology (2013) 1.12

The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg (2004) 1.08

Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the leicester general hospital. Transplantation (2003) 1.08

Hepatic microwave ablation: a review of the histological changes following thermal damage. Liver Int (2008) 1.06

Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma. PLoS One (2012) 1.05

Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. Cancer Epidemiol (2012) 1.03

Prostate MRI and 3D MR spectroscopy: how we do it. AJR Am J Roentgenol (2010) 1.02

Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J Surg Oncol (2008) 1.01

A psychometric evaluation of the Hospital Anxiety and Depression Scale in patients diagnosed with end-stage renal disease. Br J Clin Psychol (2004) 1.00

Abdominal manifestations of neurofibromatosis. J Comput Assist Tomogr (2008) 0.99

Preoperative early warning scores can predict in-hospital mortality and critical care admission following emergency surgery. J Surg Res (2008) 0.97

Total pancreatectomy with islet autotransplantation: an overview. HPB (Oxford) (2009) 0.97

Extranodal lymphoma from head to toe: part 2, the trunk and extremities. AJR Am J Roentgenol (2011) 0.97

Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability. Cancer Prev Res (Phila) (2012) 0.96

Hypoxia and angiogenesis in pancreatic cancer. ANZ J Surg (2006) 0.95

Isolated Roux-loop pancreaticojejunostomy: a series of 61 patients with zero postoperative pancreaticoenteric leaks. J Gastrointest Surg (2004) 0.95

Unplanned pregnancies among HIV-infected women in care-United States. J Acquir Immune Defic Syndr (2014) 0.95

MR enterography of Crohn disease: part 2, imaging and pathologic findings. AJR Am J Roentgenol (2011) 0.94

Predictors of severity and survival in acute pancreatitis: validation of the efficacy of early warning scores. Pancreas (2008) 0.93

Percutaneous splanchnic nerve radiofrequency ablation for chronic abdominal pain. ANZ J Surg (2005) 0.93

A prospective study of fruits, vegetables, and risk of endometrial cancer. Am J Epidemiol (2007) 0.93

A comparison of renal preservation by cold storage and machine perfusion using a porcine autotransplant model. Transplantation (2004) 0.93

Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg (2011) 0.93

Changes in interleukin-1β and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections. Am J Surg (2010) 0.92

Urinary bladder cancer: role of MR imaging. Radiographics (2012) 0.92

Subtotal hepatectomy: a porcine model for the study of liver regeneration. J Surg Res (2004) 0.91

MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls. AJR Am J Roentgenol (2011) 0.91

Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur J Cancer Prev (2009) 0.91

Bilirubin levels predict malignancy in patients with obstructive jaundice. HPB (Oxford) (2011) 0.91

Blood Transfusion Policies in Elective General Surgery: How to Optimise Cross-Match-to-Transfusion Ratios. Transfus Med Hemother (2013) 0.91

Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg (2011) 0.91

Extranodal lymphoma from head to toe: part 1, the head and spine. AJR Am J Roentgenol (2011) 0.90

The diagnosis and management of Sphincter of Oddi dysfunction: a systematic review. Langenbecks Arch Surg (2012) 0.90

Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival. J Surg Oncol (2014) 0.90

Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies. Liver Int (2008) 0.90

Ten-year experience in the management of gallbladder cancer from a single hepatobiliary and pancreatic centre with review of the literature. HPB (Oxford) (2008) 0.90

Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancer. Am J Clin Oncol (2013) 0.90

Liver electrolysis: pH can reliably monitor the extent of hepatic ablation in pigs. Clin Sci (Lond) (2002) 0.90

Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma. HPB (Oxford) (2009) 0.90

The porcine hepatic arterial supply, its variations and their influence on the extracorporeal perfusion of the liver. J Surg Res (2009) 0.89

A case of liver metastasis from an oncocytoma with a focal area of chromophobe renal cell carcinoma: a wolf in sheep's clothing. Int J Surg Pathol (2008) 0.89